Resource Center

Your hub for insights, evidence, and expertise —
from peer-reviewed publications to practical solutions

Explore our latest insights, case studies, scientific publications, and more. Whether you’re looking for evidence of impact, thought leadership, or peer-reviewed research, this is your go-to hub for resources that reflect our commitment to advancing science, improving outcomes, and supporting our clients.

Browse a wide range of content including white papers, webinars, journal articles, conference presentations, and solution briefs – all developed in collaboration with our partners and backed by real-world experience.

Publications

PRimary Care Opioid Use Disorders treatment (PROUD) trial protocol: a pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment.

2021 01 31

Journal Article

Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer: An Ancillary Study of the NRG/RTOG 9601 Randomized Clinical Trial.

2021 Apr 01

Journal Article

The design and conduct of a randomized clinical trial comparing emergency department initiation of sublingual versus a 7-day extended-release injection formulation of buprenorphine for opioid use disorder: Project ED Innovation.

2021 Mar 16

Journal Article

Buprenorphine physician-pharmacist collaboration in the management of patients with opioid use disorder: results from a multisite study of the National Drug Abuse Treatment Clinical Trials Network.

2021 Jan 11

Journal Article

Low dose recombinant full-length circumsporozoite protein-based Plasmodium falciparum vaccine is well-tolerated and highly immunogenic in phase 1 first-in-human clinical testing.

2021 Jan 22

Journal Article

Human Monoclonal Antibody Cocktail for the Treatment or Prophylaxis of Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV).

2021 Jan 28

Journal Article

Gestational and Postpartum Weight Trajectories Among Women With and Without Asthma.

May-21

Journal Article

Immunogenicity and safety of different dose schedules and antigen doses of an MF59-adjuvanted H7N9 vaccine in healthy adults aged 65 years and older.

2021 Jan 20

Journal Article

Retinal Specialist versus Artificial Intelligence Detection of Retinal Fluid from OCT: Age-Related Eye Disease Study 2: 10-Year Follow-On Study.

2020 Jun 27 ePub

Journal Article